Abnormalities of Retinoblastoma Gene Expression in Hematological Malignancies

References

• Sparkes R. S., Sparkes M. C., Wilson M. G., Towner J. W., Benedict W., Murphree A. L., Yunis J. J. Regional assignment of genes for human esterase D and retinoblastoma to chromosome band 13q14. Science 1980; 208: 1042–1044
   PubMed Web of Science ®Google Scholar
• Godbout R., Dryja T. P., Squire J., Gallie B. L., Phillips R. A. Somatic inactivation of genes on chromosome 13 is a common event in both hereditary and nonhereditary retinoblastoma tumors. Nature 1983; 304: 451–453
   PubMed Web of Science ®Google Scholar
• Friend S. H., Bernards R., Rogelj S., Weinberg R. A., Rapaport J. M., Albert D. M., Dryja T. P. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986; 323: 643–646
   PubMed Web of Science ®Google Scholar
• Lee W.-H., Bookstein R., Hong F., Young L.-J., Shew J.-Y., Lee E. Y.-H. P. Human retinoblastoma susceptibility gene: cloning, identification and sequence. Science 1987; 235: 1394–1399
   PubMed Web of Science ®Google Scholar
• Fung Y. K. T., Murphree A. L., T Ang A., Qian J., Hinrishs S. H., Benedict W. F. Structural evidence for the authenticity of the human retinoblastoma gene. Science 1987; 236: 1657–1661
   PubMed Web of Science ®Google Scholar
• Hong F. D., Huang H.-J. S., To H., Young L.-J. S., Oro A., Bookstein R., Lee E. Y.-H. P., Lee W.-H. Structure of the human retinoblastoma gene. Proc. Natl. Acad. Sci. USA 1989; 86: 5502–5506
   PubMed Web of Science ®Google Scholar
• Mihara K., Cao X. R., Yen A., Chandler S., Driscoll B., Murphree A. L., Tang A., Fung Y.-K. T. Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product. Science 1989; 246: 1300–1303
   PubMed Web of Science ®Google Scholar
• Chen P.-L., Scully P., Shew J.-Y., Wang J. Y. J., Lee W.-H. Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 1989; 58: 1193–1198
   PubMed Web of Science ®Google Scholar
• DeCaprio J. A., Ludlow J. W., Lynch D., Furukawa Y., Griffin J., Piwnica-Worms H., Huang C. M., Livingston D. M. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 1989; 58: 1085–1095
   PubMed Web of Science ®Google Scholar
• Buchkovich K., Duffy L. A., Harlow E. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 1989; 58: 1097–1105
   PubMed Web of Science ®Google Scholar
• Ludlow J. W., Shon J., Pipas J. M., Livingston D. M., DeCaprio J. A. The retinoblastoma susceptibility gene product undergoes cell cycle-dependent dephosphorylation and binding to and release from SV40 large T. Cell 1990; 60: 387–396
   PubMed Web of Science ®Google Scholar
• Nasmyth K., Hunt T. Dams and Sluices. Nature 1993; 366: 634–635
   PubMed Web of Science ®Google Scholar
• Akiyama T., Ohuchi T., Sumida S., Matsumoto K., Toyoshima K. Phosphorylation of the retinoblastoma protein by cdk2. Proc. Natl. Acad. Sci. USA 1992; 89: 7900–4
   PubMed Web of Science ®Google Scholar
• Ewen M. E., Sluss H. K., Whitehouse L. L., Livingstone D. M. TGF-beta inhibition of cdk4 synthesis is linked to cell cycle arrest. Cell 1993; 74: 1009–1020
   PubMed Web of Science ®Google Scholar
• Fattacy A., Helin R., Harlow E. Transcriptional inhibition by the retinoblastoma protein. Philosophical Trans. Royal Soc. (London) Series B. Biol. Sci 1993; 340: 333–336
   Web of Science ®Google Scholar
• Nevins J. R. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 1992; 258: 424–429
   PubMed Web of Science ®Google Scholar
• Ewen M. E., Sluss H. K., Sher C. J., Matsushime H., Kato J., Livingston D. M. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 1993; 73(3)487–497
   PubMed Web of Science ®Google Scholar
• Robbins P. D., Horowitz J. M., Mulligan R. C. Negative regulation of human c-fos expression by the retinoblastoma gene product. Nature 1990; 346: 668–671
   PubMed Web of Science ®Google Scholar
• Santhanam U., Ray A., Sehgal P. Repression of the interleukin-6 gene promoter by p53 and the retinoblastoma susceptibility gene product. Proc. Natl. Acad. Sci. USA 1991; 88: 7605–7609
   PubMed Web of Science ®Google Scholar
• Kim S.-J., Lee H.-D., Robbins P. D., Busam K., Sporn M. B., Roberts A. B. Regulation of transforming growth factor β, gene expression by the product of the retinoblastoma—susceptibility gene. Proc. Natl. Acad. Sci. USA 1991; 88: 3052–56
   PubMed Web of Science ®Google Scholar
• Kim S.-J., Wagner S., Liu F., O'Reilly M. A., Robbins P. D., Green M. R. Retinoblastoma gene product activates expression of the human TGF-β2 gene through transcription factor ATF-2. Nature 1992; 358: 331–334
   PubMed Web of Science ®Google Scholar
• Bookstein R., Shew J.-Y., Chen P.-L., Scully P., Lee W.-H. Suppression of tumorogenecity of human prostate carcinoma cells by replacing a mutated Rb gene. Science 1990; 247: 712–715
   PubMed Web of Science ®Google Scholar
• Huang H.-J. S., Yee J.-K., Shew J.-Y., Chen P.-L., Bookstein R., Friedmann T., Lee E. Y.-H. P., Lee W. H. Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science 1988; 242: 1563–1566
   PubMed Web of Science ®Google Scholar
• Takahashi R., Hashimoto T., Xu H.-J., Hu S.-X., Maatsui T., Miki T., Bigo-Marshall H., Aaronson S. A., Benedict W. F. The retinoblastoma gene functions as a growth and tumor suppressor in human bladder carcinoma cells. Proc. Natl. Acad. Sci. USA 1991; 88: 5257–5261
   PubMed Web of Science ®Google Scholar
• Hunter T. Braking the cycle. Cell 1993; 75: 839–841
   PubMed Web of Science ®Google Scholar
• DeCaprio J. A., Ludlow J. W., Figge J., Shew J. Y., Huang C. M., Lee W. H., Marsilio E., Paucha E., Livingston D. M. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 1988; 54: 275–83
   PubMed Web of Science ®Google Scholar
• Whyte P., Buchkovitch K. J., Horowitz J. M., Friend S. H., Raybuck J., Weinberg R. A., Harlow E. Association between an oncogene and an anti-oncogene: The adenovirus EIA proteins bind to the retinoblastoma gene product. Nature 1988; 334: 124–129
   PubMed Web of Science ®Google Scholar
• Dyson N., Howley P. M., Munger K., Harlow E. The human papilloma virus-16E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 1989; 243: 934–937
   PubMed Web of Science ®Google Scholar
• Lee W. H., Shew J. Y., Hong F. D., Sery T. W., Donoso L. A., Young L. J., Bookstein R., Lee E. Y.-H. P. The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity. Nature 1987; 329: 642–645
   PubMed Web of Science ®Google Scholar
• Dunn J. M., Phillips R. A., Becker A. J., Gallie B. L. Identification of germline and somatic mutations affecting the retinoblastoma gene. Science 1988; 241: 1797–1800
   PubMed Web of Science ®Google Scholar
• Horowitz J. W., Park S. H., Bogenmann E., Cheng J. C., Yandell D. W., Kaye F. J., Miuua J. D., Dryja T. P., Weinberg R. A. Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells. Proc. Natl. Acad. Sci. USA 1990; 87: 2775–2779
   PubMed Web of Science ®Google Scholar
• Presti J. C., Reuter V. C., Galan T., Fair W. R., Cordon-Cardo C. Molecular genetic alterations in superficial and locally advanced human bladder cancer. Cancer Res 1991; 51: 5405–5409
   PubMed Web of Science ®Google Scholar
• Ishikawa J., Xu H.-J., Hu S.-X., Yandell D. W., Maeda S., Kamidono S., Benedict W. F., Takahashi R. Inactivation of the retinoblastoma gene in human bladder and renal cell carcinomas. Cancer Res 1991; 51: 5736–5743
   PubMed Web of Science ®Google Scholar
• Horowitz J. W., Yandell D. W., Park S.-H., Canning S., Whyte P., Buchkovich K. J., Harlow E., Weinberg R. A., Dryja T. P. Point mutational inactivation of the retinoblastoma antioncogene. Science 1989; 243: 937–940
   PubMed Web of Science ®Google Scholar
• Bookstein R., Rio P., Madreperla S. A., Hong F., Allred C., Grizzle W. E., Lee W.-H. Promoter deletion and loss of etinoblastoma gene expression in human prostate carcinoma. Proc. Natl. Acad. Sci. USA 1990; 87: 7762–7766
   PubMed Web of Science ®Google Scholar
• Harbour J. W., Lai S.-L., Whang-Peng J., Gazdar A. F., Minna J. D., Kaye E. J. Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science 1988; 241: 353–357
   PubMed Web of Science ®Google Scholar
• Yokoto J., Akiyama T., Fung Y. K. T., Benedict W. F., Namba Y., Hanaoka M., Wada M., Terasaki T., Shimosato Y., Sugimura T., Terada M. Altered expression of the retinoblastoma (Rb) gene in small-cell carcinoma of the lung. Oncogene 1988; 3: 471–475
   PubMed Web of Science ®Google Scholar
• Lee E. Y.-H. P., To H., Shew J. Y., Bookstein R., Scully P., Lee W. H. Inactivation of the retinoblastoma susceptibility gene in human breast carcinoma. Science 1988; 241: 218–221
   PubMed Web of Science ®Google Scholar
• Tang A., Varley J. M., Chkraborty S., Murphree A. L., Fung Y. K. T. Structural rearrangement of the retinoblastoma gene in human breast carcinoma. Science 1988; 242: 263–266
   PubMed Web of Science ®Google Scholar
• Cance W. G., Brennan M. F., Dudas M. E., Huang C.-M., Cordon-Cardo C. Altered expression of the retinoblastoma gene product in human sarcomas. New Engl. J. Med 1990; 323: 1457–1462
   PubMed Web of Science ®Google Scholar
• Togushida J., Ishizaki K., Sasaki M. S., Ikenega M., Sugimoto M., Kotoura Y., Yamamuro T. Chromosomal reorganization for the expression of recessive mutation of retinoblastoma susceptibility gene in te development of osteosarcoma. Cancer Res 1988; 48: 3939–3943
   PubMed Web of Science ®Google Scholar
• Lee E. Y.-H. P., Chang C.-Y., Hu N., Wang Y.-C. J., Lai C.-C., Herrup K., Lee W.-H., Bradley A. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 1992; 359: 288–294
   PubMed Web of Science ®Google Scholar
• Furukawa Y., DeCaprio J. A., Freedman A., Rankura Y., Nakamura M., Ernst T. J., Livingston D. M., Griffin J. D. Expression and state of phosphorylation of the retinoblastoma susceptibility gene product in cycling and noncycling human hematopoietic cells. Proc. Natl. Acad. Sci. USA 1990; 87: 2770–2774
   PubMed Web of Science ®Google Scholar
• Hazfield J., Li M.-L., Brown E. L., Sookdeo H., Levesque J.-P., O'Tode T., Gurney C., Clark S. C., Hazfield A. Release of early human hematopoietic progenitors from quiescence by antisense transforming growth factor β₁ or Rb oligonucleotides
   Google Scholar
• Tang T.-L., Yeh S.-H., Chen P.-J., Lin M.-T., Tien H.-F., Chen Y.-C. Inactivation of the retinohlastoma gene in acute myelogenous leukaemia. Br. J. Haemat 1992; 82: 502–507
   PubMed Web of Science ®Google Scholar
• Kornblau S. M., Xu H.-J., Giglio A. D., Hu S.-X., Zhang W., Calvert L., Beran M., Estey E., Andreeff M., Trujillo J., Cork M. A., Smith T. L., Benedict W. F., Deisseroth A. B. Clinical implications of decreased retinoblastoma protein expression in acute myelogenous leukemia. Cancer Res 1992; 52: 4587–4590
   PubMed Web of Science ®Google Scholar
• Zhu Y.-M., Bradbury D., Russell N. Decreased retinoblastoma protein expression in acute myeloblastic leukaemia is associated with the autonomous proliferation of clongenic blasts. Br. J. Haemat 1994; 86: 533–539
   PubMed Web of Science ®Google Scholar
• Weide R., Parviz B., Pflüger K.-H., Havemann K. Altered expression of the human retinoblastoma gene in monocytic leukaemias. Br. J. Haemat 1993; 83: 428–432
   PubMed Web of Science ®Google Scholar
• Ahuja H. G., Jat P. S., Foti A., Bar-Eli M., Cline M. T. Abnormalities of the retinoblastoma gene in the pathogenesis of acute leukemia. Blood 1991; 78: 3259–3268
   PubMed Web of Science ®Google Scholar
• Furukawa Y., DeCaprio J. A., Belvin M., Griffin J. D. Heterogenous expression of the retinoblastoma susceptibility gene in primary human leukemia cells. Oncogene 1991; 6: 1343–1346
   PubMed Web of Science ®Google Scholar
• Kornblau S. M., Xu H.-J., Zhang W., Hu S.-X., Beran M., Smith T. L., Hester J., Estey E., Benedict W. F., Deisseroth A. B. Levels of retinoblastoma protein expression in newly diagnosed acute myelogenous leukemia. Blood 1994; 84: 256–261
   PubMed Web of Science ®Google Scholar
• Zhang W., Xu H.-J., Kornblau S., Drach J., Hu S.-X., Andreeff M., Benedict W., Deisseroth A. B. Growth factor induction reveals two mechanisms of retinoblastoma gene inactivation in human acute myelogenous leukemia cells. Blood 1993; 82: 124a, Supl.
   Web of Science ®Google Scholar
• Chen Y. C., Chen P. J., Yeh S. H., Tien H. F., Wang C. H., Tang J. L., Hong R. L. Deletion of human retinoblastoma gene in primary leukemias. Blood 1990; 76: 2060–2064
   PubMed Web of Science ®Google Scholar
• Towatari M., Adachi K., Kato H., Saito H. Absence of the human retinoblastoma gene product in the megakaryoblastic crisis of chronic myelogenous leukemia. Blood 1991; 78: 2178–2181
   PubMed Web of Science ®Google Scholar
• Ginsberg A. M., Raffeld M., Cossman J. Inactivation of the retinoblastoma gene in human lymphoid neoplasms. Blood 1991; 77: 833–840
   PubMed Web of Science ®Google Scholar
• Cheng J., Scully P., Shew J. Y., Lee W. H., Vila V., Haas M. Homozygous deletion of the retinoblastoma gene in an acute lymphoblastic leukemia (T) cell line. Blood 1990; 75: 730–735
   PubMed Web of Science ®Google Scholar
• Liu Y., Grander D., Söderhäll S., Juliusson G., Gahrton G., Einhorn S. Retinoblastoma gene deletions in B-cell chronic lymphocytic leukaemia. Genes, Chrom. & Cancer 1992; 4: 250–256
   PubMed Web of Science ®Google Scholar
• Stilgenbauer S., Döhner H., Bulgay-Morschel M., Weitz S., Bentz M., Licter P. High frequency of monoallelic retinoblastoma gene deletion in B-cell chronic lymphocytic leukemia revealed by interphase cytogenetics. Blood 1993; 81: 2118–2124
   PubMed Web of Science ®Google Scholar
• Kornblau S. M., Chen N., del Giglio A., O'Brien S., Deisseroth A. B. Retinoblastoma protein expression is frequently altered in chronic lymphocytic leukemia. Cancer Res 1994; 54: 242–246
   PubMed Web of Science ®Google Scholar
• Weide R., Dowding C., Sucai B., Bungey J., Chase A., Goldman J. Inactivation of the retinoblastoma susceptibility gene in a human high grade non-Hodgkin's lymphoma cell line. Br. J. Heamat 1991; 78: 500–505
   PubMed Web of Science ®Google Scholar
• Weide R., Tiemann M., Pfluger K.-H., Koppler H., Parvizl B., Wacker H.-H., Kreipe H.-H., Havemann K., Parwaresh M. R. Alterd expression of the retinoblastoma gene product in human high grade non-Hodgkin's lymphomas. Leukemia 1994; 8: 97–101
   PubMed Web of Science ®Google Scholar
• Corradini P., Inghirami G., Astolfi M., Ladetto M., Voena C., Ballerini P., Gu W., Nilsson K., Knowles D. M., Bocadorro M., Pileri A., Dalla-Favera R. Inactivation of tumor suppressor genes, p53 and Rb in plasrna cell dyscrasias. Leukemia 1994; 8: 758–767
   PubMed Web of Science ®Google Scholar
• Tricot G., Dao D., Gazitt Y., Epstein J., Sawyer J., Hoover R., Barlogie B. Deletion of the retinoblastoma gene (Rb-1) in multiple myeloma (MM). Blood 1993; 82: 261a, Supl.
   Web of Science ®Google Scholar
• Johnson D. D., Dewald G. W., Pierre R., Letendre L., Silverstein M. N. Deletions of chromosome 13 in malignant hematologic disorders. Cancer Genet. Cytogenet 1985; 18: 235–241
   PubMed Web of Science ®Google Scholar
• Fung Y. K., Tang A. The role of retinoblastoma gene in breast cancer development. Cancer Treatment & Res 1992; 61: 59–68
   PubMedGoogle Scholar
• Logathetis J., Xu H.-J., Ro J. Y. Hu. S.-X., Sahin A., Ordonez N., Benedict W. Altered expression of retinoblastoma protein and known prognostic variables in localy advance bladder cancer. J. Natl. Cancer Inst 1992; 84: 1257–1261
   Google Scholar
• Hunter A. E., Rogers S. Y., Roberts I. A. G., Barrett A. J., Russell N. Autonomous growth of blast cells is associated with reduced survival in acute myeloblastic leukemia. Blood 1993; 82: 899–903
   PubMed Web of Science ®Google Scholar
• Löwenberg B., van Potten W. L. J., Touw I., Delwel R., Santini V. Autonomous proliferaton of leukemic cells in vitro as a determinant of prognosis in adult myeloid leukemia. New Engl. J. Med 1992; 328: 614–619
   Web of Science ®Google Scholar
• Reilly I. A. G., Kozlowski R., Russell N. H. Heterogenous mechanisms of autocrine growth of AML blasts. Br. J. Haemat 1989; 72: 363–369
   PubMed Web of Science ®Google Scholar
• Young D. C., Demetri G. D., Ernst T. J., Cannistra S. A., Griffin J. D. In Vitro expression of colony—stimulating factor genes by human acute myeloblastic leukemia cells. Exp. Hemat 1988; 16: 378–382
   PubMed Web of Science ®Google Scholar
• Griffin J. D., Rambaldi A., Vellenga E., Young D. C., Ostapovicz D., Cannistra S. A. Secretion of interleukin-1 by acute myeloblastic leukemia cells in vitro induces endothelial cells to secrete colony stimulating factors. Blood 1987; 70: 1218–1221
   PubMed Web of Science ®Google Scholar
• Bradbury D., Bowen G., Kozlowski R., Reilly I., Russell N. Endogenous interleukin-1 can regulate autonomous growth of acute myeloblastic leukemia cells by inducing autocrine secretoin of GM-CSF. Leukemia 1990; 4: 44–47
   PubMed Web of Science ®Google Scholar
• Oster W., Cicco N. A., Klein H., Hirang T., Kishimoto T., Lindemann A., Mertelsmann R. H., Herrmann F. Participation of cytokines interleukin-6 tumour necrosis factoralpha, interleukin-1-beta secreted by acute myelogenous leukemia blasts in autocrine and paracrine leukemia growth control. J. Clin. Invest 1989; 84: 451–457
   PubMed Web of Science ®Google Scholar
• Van der Schoot C. E., Jansen P., Poorter M., Wester M. R., von dem Kr., Borne A. E. G., Aarden L. A., Oers R. H. J. Interleukin-6 and interleukin-1 production in acute leukemia with monocytoid differentiation. Blood 1989; 74: 2081–2087
   PubMed Web of Science ®Google Scholar
• Russell N. H. Autocrine growth factors and leukaemic haemopoiesis. Blood Rev 1992; 6: 149–156
   PubMed Web of Science ®Google Scholar
• Zhu Y.-M., Bradbury D. A., Keith F. J., Russell N. Absence of retinoblastoma protein expression results in autocrine production of interleukin-6 and promotes the autonomous growth of acute myeloid leukemia blast cells. Leukemia, (accepted for publication)
   Google Scholar
• Brach M. A., Lowenberg B., Mantovani L., Schwulera U., Mertelsmann R., Herrman F. Interleukin-6 (IL-6) as an intermediate in II-1 induced proliferation of leukemic human megakaryoblasts. Blood 1990; 76: 1972–1979
   PubMed Web of Science ®Google Scholar
• Kawano M., Hirano T., Matsuda T., Taga T., Horii Y., Iwato K., Asaoku H., Tang B., Tanabe O., Tanaka H., Kuramoto A., Kishimoto T. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 1988; 332: 83–85
   PubMed Web of Science ®Google Scholar
• Bataille R., Jourdan M., Zhang X. G., Klein B. Serum levels of IL-6, apotent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias. J. Clin. Invest 1989; 84: 2008–2011
   PubMed Web of Science ®Google Scholar
• Ludwig H., Nachbaur D. M., Fritz E. Interleukin 6 as a prognostic factor in myeloma. Blood 1991; 77: 2794–2795
   PubMed Web of Science ®Google Scholar